CI
CX Institutional’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $172K | Buy |
1,370
+55
| +4% | +$6.91K | 0.01% | 674 |
|
|
2025
Q1 | $180K | Buy |
+1,315
| New | +$180K | 0.01% | 626 |
|
|
2024
Q3 | – | Sell |
-1,005
| Closed | -$233K | – | 556 |
|
|
2024
Q2 | $233K | Buy |
+1,005
| New | +$233K | 0.01% | 507 |
|
|
2024
Q1 | – | Sell |
-865
| Closed | -$224K | – | 546 |
|
|
2023
Q4 | $224K | Buy |
+865
| New | +$224K | 0.01% | 469 |
|
|
2023
Q3 | – | Sell |
-712
| Closed | -$203K | – | 487 |
|
|
2023
Q2 | $203K | Buy |
+712
| New | +$203K | 0.01% | 500 |
|
|
2022
Q3 | – | Sell |
-93
| Closed | -$19K | – | 525 |
|
|
2022
Q2 | $19K | Buy |
+93
| New | +$19K | ﹤0.01% | 850 |
|
|
2021
Q4 | – | Sell |
-320
| Closed | -$91K | – | 392 |
|
|
2021
Q3 | $91K | Sell |
320
-15
| -4% | -$4.27K | 0.01% | 464 |
|
|
2021
Q2 | $116K | Buy |
335
+97
| +41% | +$33.6K | 0.01% | 416 |
|
|
2021
Q1 | $67K | Buy |
238
+30
| +14% | +$8.45K | 0.01% | 430 |
|
|
2020
Q4 | $51K | Buy |
208
+63
| +43% | +$15.4K | ﹤0.01% | 434 |
|
|
2020
Q3 | $41K | Buy |
145
+77
| +113% | +$21.8K | ﹤0.01% | 417 |
|
|
2020
Q2 | $18K | Sell |
68
-19
| -22% | -$5.03K | ﹤0.01% | 460 |
|
|
2020
Q1 | $28K | Buy |
87
+30
| +53% | +$9.66K | ﹤0.01% | 343 |
|
|
2019
Q4 | $17K | Buy |
57
+36
| +171% | +$10.7K | ﹤0.01% | 362 |
|
|
2019
Q3 | $5K | Sell |
21
-32
| -60% | -$7.62K | ﹤0.01% | 568 |
|
|
2019
Q2 | $12K | Buy |
53
+1
| +2% | +$226 | ﹤0.01% | 456 |
|
|
2019
Q1 | $12K | Buy |
+52
| New | +$12K | ﹤0.01% | 434 |
|